WORK Medical Technology Group LTD (WOK)

Healthcare · NCM

$1.77-2.21% today

Price as at 1 Oct 2026, 03:57 UTC. Quotes are delayed.

Fundamentals

Market cap$4.93M
Revenue growth (YoY)-14.4%
Profit margin-10.9%
Return on equity-6.5%
52-week range$1.75 to $105,000.00

Valuation and ratings

Fair value estimate$4.49
Upside to fair value+153.7%
Moat score17/100
Overall rating48/100, moderate quality

Fair value: $4.49 (+153.7%), see how we got there

WORK Medical Technology Group LTD trades at $1.77, which is 154% below the $4.49 our fair value estimate puts on the business. On that measure alone it screens as undervalued, though a valuation model is an argument rather than a measurement, and the market is frequently right about why something is cheap.

Our moat model scores it 17 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

About WORK Medical Technology Group LTD

WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD has strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to develop data-model-application trinity for intelligent medical models. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.

Industry: Medical DevicesEmployees: 238HQ: China

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

WOK passes 2 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

WOK peers

The largest companies in the same industry (Medical Devices), then in the same sector.

Every healthcare company we cover is on the Healthcare hub.

Common questions

Is WORK Medical Technology Group LTD (WOK) undervalued?

Against our fair value estimate of $4.49, WOK at $1.77 is 154% below fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.

Where does SteadyShares get its WOK data?

Fundamentals for WOK come from company filings and exchange data, as listed on NCM; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 03:57 UTC and is delayed. Our data quality score for this company is 79/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for WOK, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.